IN2015KN00492A - - Google Patents
Info
- Publication number
- IN2015KN00492A IN2015KN00492A IN492KON2015A IN2015KN00492A IN 2015KN00492 A IN2015KN00492 A IN 2015KN00492A IN 492KON2015 A IN492KON2015 A IN 492KON2015A IN 2015KN00492 A IN2015KN00492 A IN 2015KN00492A
- Authority
- IN
- India
- Prior art keywords
- compounds
- diseases
- conditions
- diabetes
- infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Otolaryngology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
This invention relates to sphingoglycolipid analogues, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection atopic disorders, autoimmune disease, diabetes or cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ60147312 | 2012-07-26 | ||
PCT/NZ2013/000133 WO2014017928A1 (en) | 2012-07-26 | 2013-07-26 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015KN00492A true IN2015KN00492A (en) | 2015-07-17 |
Family
ID=49997620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN492KON2015 IN2015KN00492A (en) | 2012-07-26 | 2013-07-26 |
Country Status (9)
Country | Link |
---|---|
US (1) | US9586985B2 (en) |
EP (1) | EP2877481B1 (en) |
JP (1) | JP6528029B2 (en) |
KR (1) | KR102162619B1 (en) |
CN (1) | CN104736550B (en) |
AU (1) | AU2013293646B2 (en) |
CA (1) | CA2880191C (en) |
IN (1) | IN2015KN00492A (en) |
WO (1) | WO2014017928A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2893918C (en) * | 2012-12-06 | 2020-11-24 | Callaghan Innovation Research Limited | Conjugate compounds |
WO2014200363A1 (en) * | 2013-06-10 | 2014-12-18 | Victoria Link Limited | Sphingoglycolipid analogues |
WO2015187040A1 (en) * | 2014-06-05 | 2015-12-10 | Regan James Anderson | Amino sphingoglycolipid analogues |
JP6453033B2 (en) * | 2014-10-22 | 2019-01-16 | 国立大学法人北海道大学 | Method for producing sugar sphingosine and sphingo base |
US9394312B1 (en) * | 2015-06-14 | 2016-07-19 | Mark Quang Nguyen | Ibrutinib prodrugs, pharmaceutical compositions thereof, and methods of use |
WO2017083830A1 (en) * | 2015-11-13 | 2017-05-18 | La Jolla Institute For Allergy And Immunology | Sphingamide compounds and methods for binding inkt cells |
WO2017163808A1 (en) * | 2016-03-22 | 2017-09-28 | 学校法人慶應義塾 | Compound or salt thereof, natural killer t cell activator, and pharmaceutical composition |
WO2019122050A1 (en) | 2017-12-22 | 2019-06-27 | Isa Pharmaceuticals B.V. | Methods of immunization |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4410913B2 (en) * | 2000-06-12 | 2010-02-10 | 壽製薬株式会社 | Process for producing novel glycolipid derivatives |
EP1611147A4 (en) | 2003-03-20 | 2007-10-17 | Univ Brigham Young | 6"-amino-6"-deoxygalactosylceramides |
JP3824319B2 (en) * | 2004-02-19 | 2006-09-20 | 株式会社紀文フードケミファ | Antiviral composition |
US20060024691A1 (en) * | 2004-03-25 | 2006-02-02 | Buck Institute For Age Research | Novel pathways in the etiology of cancer |
KR101377116B1 (en) * | 2004-08-27 | 2014-03-24 | 알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 | Ceramide derivatives as modulators of immunity and autoimmunity |
US7923013B2 (en) * | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
JP5090928B2 (en) * | 2004-12-28 | 2012-12-05 | ザ ロックフェラー ユニバーシティ | Glycolipids and their analogs as antigens for NKT cells |
US20090117089A1 (en) * | 2005-09-19 | 2009-05-07 | The Rockefeller University | Glycolipids and analogues thereof as antigens for nk t cells |
WO2008047174A1 (en) * | 2006-10-18 | 2008-04-24 | Centre National De La Recherche Scientifique | Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
US20080133801A1 (en) * | 2006-12-04 | 2008-06-05 | Aten International Co., Ltd. | Keyboard-video-mouse switch system for switching between computers having a plurality of video sources each and switching method thereof |
CN104478093B (en) | 2007-04-12 | 2016-06-01 | 诺维信生物股份有限公司 | Wastewater treatment |
EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
CN102215864A (en) * | 2008-10-08 | 2011-10-12 | 威蒂赛尔公司 | Vaccine composition for use against influenza |
-
2013
- 2013-07-26 US US14/417,487 patent/US9586985B2/en active Active
- 2013-07-26 KR KR1020157004813A patent/KR102162619B1/en active IP Right Grant
- 2013-07-26 IN IN492KON2015 patent/IN2015KN00492A/en unknown
- 2013-07-26 CN CN201380050112.1A patent/CN104736550B/en active Active
- 2013-07-26 WO PCT/NZ2013/000133 patent/WO2014017928A1/en active Application Filing
- 2013-07-26 EP EP13823249.1A patent/EP2877481B1/en active Active
- 2013-07-26 JP JP2015524218A patent/JP6528029B2/en not_active Expired - Fee Related
- 2013-07-26 CA CA2880191A patent/CA2880191C/en active Active
- 2013-07-26 AU AU2013293646A patent/AU2013293646B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2880191A1 (en) | 2014-01-30 |
CN104736550A (en) | 2015-06-24 |
EP2877481A1 (en) | 2015-06-03 |
WO2014017928A1 (en) | 2014-01-30 |
EP2877481B1 (en) | 2019-11-27 |
CN104736550B (en) | 2017-12-29 |
AU2013293646A1 (en) | 2015-03-12 |
KR102162619B1 (en) | 2020-10-08 |
US9586985B2 (en) | 2017-03-07 |
US20150191503A1 (en) | 2015-07-09 |
CA2880191C (en) | 2021-04-20 |
JP6528029B2 (en) | 2019-06-12 |
JP2015522656A (en) | 2015-08-06 |
KR20150073942A (en) | 2015-07-01 |
EP2877481A4 (en) | 2016-04-06 |
AU2013293646B2 (en) | 2017-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018236800B2 (en) | DNA-PK inhibitors | |
IN2015KN00492A (en) | ||
NZ708727A (en) | Conjugate compounds | |
PH12016501966A1 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
PH12016501192B1 (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
NZ724878A (en) | Compounds and compositions as toll-like receptor 7 agonists | |
MX2017005834A (en) | Aadc polynucleotides for the treatment of parkinson's disease. | |
MD20150091A2 (en) | Anti-viral compounds | |
TW201613901A (en) | New compounds | |
GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
WO2015085318A3 (en) | Targeted adaptive vaccines | |
NZ700928A (en) | Dna-pk inhibitors | |
MY165579A (en) | Synthetic methods for spiro-oxindole compounds | |
PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
EA201490423A1 (en) | METHODS AND COMPOSITIONS RELATED TO p62 FOR TREATMENT AND PREVENTION OF CANCER | |
MX2020006237A (en) | Compounds for treatment of diseases related to dux4 expression. | |
PH12014502032A1 (en) | Treatment of brain cancer | |
WO2013120022A3 (en) | Treatment of hypoglycemia | |
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
WO2014086453A8 (en) | Azaheterobicyclic compounds | |
MY192609A (en) | Substituted bicyclic heteroaryl compounds as rxr agonists | |
IN2013MU03118A (en) | ||
PH12017501872A1 (en) | Methods of treating diseases | |
PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs |